BrightSpire Capital, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that BrightSpire Capital, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $330.59M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $358.81M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $415.08M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $364.62M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $194.31M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $291.01M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $588.60M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $500.79M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $189.46M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $158.27M | Mar 1, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($31.15M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($131.98M) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | ($15.55M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $45.79M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($101.05M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | ($353.30M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | ($414.51M) | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | ($168.50M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $88.50M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $76.05M | Mar 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.03M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $103.41M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $137.62M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $125.28M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | ($21.27M) | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $96.36M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $137.18M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $100.72M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $106.98M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $88.51M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.56B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $3.72B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $4.20B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $4.75B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $5.64B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $6.21B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $7.41B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $8.66B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.84B | Mar 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.64B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.68B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.92B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $3.36B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $4.15B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $4.25B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $5.21B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $5.82B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $431.83M | Mar 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $938.43M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $1.28B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $1.39B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.46B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.67B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.12B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.71B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.08B | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.93B) | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | ($1.81B) | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | ($1.59B) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($1.47B) | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | ($1.41B) | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | ($1.23B) | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | ($819.74M) | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | ($193.33M) | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $258.78M | Mar 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $66.79M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $302.17M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $257.51M | Feb 18, 2026 |
| FY2025 | Dec 31, 2022 | $306.32M | Feb 18, 2026 |
| FY2024 | Dec 31, 2021 | $259.72M | Feb 19, 2025 |
| FY2023 | Dec 31, 2020 | $474.82M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $69.62M | Feb 21, 2023 |
| FY2021 | Dec 31, 2018 | $77.32M | Feb 22, 2022 |
| FY2020 | Dec 31, 2017 | $25.20M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $13.98M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.47B | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $2.49B | Feb 18, 2026 |
| FY2024 | Dec 31, 2023 | $2.72B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $3.16B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $3.17B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.39B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $3.19B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.62B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $389.66M | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | (3) | Feb 22, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | (2) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | (3) | Feb 22, 2022 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.00M | Feb 18, 2026 |
| FY2025 | Dec 31, 2024 | $99.06M | Feb 18, 2026 |
| FY2025 | Dec 31, 2023 | $103.95M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $99.39M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $51.92M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $51.71M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $217.72M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $185.29M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $0 | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Mar 1, 2019 |